Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.7B | 10.2B | 10.3B | 9.5B |
Cost of revenue | 7.9B | 7.6B | 7.6B | 7.0B |
Gross profit | 2.8B | 2.6B | 2.7B | 2.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.1B | 1.0B | 1.0B | 931.9M |
Operating income | 850.2M | 720.6M | 793.4M | 719.7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 29.8M | 29.9M | 19.7M | 22.4M |
Other income expense | — | — | — | — |
Pretax income | 874.1M | 785.3M | 821.9M | 760.3M |
Tax provision | 230.5M | 184.2M | 192.7M | 184.4M |
Net income | 643.6M | 601.1M | 629.2M | 575.9M |
Basic EPS | — | 4.2 | 4.4 | 4.0 |
Diluted EPS | — | 4.2 | 4.4 | 4.0 |
Basic average shares | — | 143.8M | 143.6M | 143.6M |
Diluted average shares | — | 143.8M | 143.6M | 143.6M |
EBITDA | 1.1B | 1.0B | 1.0B | 970.4M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |